Stocks · Health care · Pharmaceutical Preparations

Mirum Pharmaceuticals, Inc.

MIRM Clue Score61
United States Fiscal year ends December CIK 0001759425 Results filed 3 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Christopher Peetz
4 Nov 2026
Chief Executive Officer
Sold after exercise
20,000
$90.00
$1.80M
Christopher Peetz
1 Sep 2026
Chief Executive Officer
Sold after exercise
21,688
$98.91
$2.15M
Christopher Peetz
1 Sep 2026
Chief Executive Officer
Sold after exercise
8,312
$98.08
$815.24K
Jolanda Howe
18 Aug 2026
SVP, Global Controller
Sold after exercise
40,000
$100.00
$4.00M
Christopher Peetz
10 Aug 2026
Chief Executive Officer
Sold after exercise
2,300
$100.14
$230.32K
Christopher Peetz
10 Aug 2026
Chief Executive Officer
Sold after exercise
6,017
$99.25
$597.19K
Christopher Peetz
10 Aug 2026
Chief Executive Officer
Sold after exercise
11,683
$98.51
$1.15M
Christopher Peetz
6 Jul 2026
Chief Executive Officer
Sold after exercise
1,710
$124.79
$213.39K
Christopher Peetz
6 Jul 2026
Chief Executive Officer
Sold after exercise
1,975
$123.74
$244.39K
Christopher Peetz
6 Jul 2026
Chief Executive Officer
Sold after exercise
4,181
$122.34
$511.50K
Christopher Peetz
6 Jul 2026
Chief Executive Officer
Sold after exercise
12,134
$121.65
$1.48M
Christopher Peetz
1 Jun 2026
Chief Executive Officer
Sold after exercise
883
$99.66
$88.00K
Christopher Peetz
1 Jun 2026
Chief Executive Officer
Sold after exercise
1,021
$98.20
$100.26K
Christopher Peetz
1 Jun 2026
Chief Executive Officer
Sold after exercise
1,973
$97.56
$192.49K
Christopher Peetz
1 Jun 2026
Chief Executive Officer
Sold after exercise
6,926
$96.15
$665.93K
Christopher Peetz
1 Jun 2026
Chief Executive Officer
Sold after exercise
16,595
$95.34
$1.58M
Christopher Peetz
1 Jun 2026
Chief Executive Officer
Sold after exercise
2,602
$94.64
$246.25K
Saira Ramasastry
15 May 2026
Director
Sold after exercise
2,000
$109.47
$218.94K
Saira Ramasastry
15 Apr 2026
Director
Sold after exercise
2,000
$96.90
$193.80K
Saira Ramasastry
16 Mar 2026
Director
Sold after exercise
2,000
$90.76
$181.52K
Saira Ramasastry
13 Feb 2026
Director
Sold after exercise
2,000
$102.09
$204.18K
Saira Ramasastry
15 Jan 2026
Director
Sold after exercise
2,000
$90.99
$181.98K
Saira Ramasastry
22 Dec 2025
Director
Sold after exercise
5,000
$80.00
$400.00K
Michael G Grey
19 Dec 2025
Director
Sold after exercise
50,000
$78.00
$3.90M
Saira Ramasastry
18 Dec 2025
Director
Sold after exercise
1,000
$70.00
$70.00K
Saira Ramasastry
18 Dec 2025
Director
Sold after exercise
1,000
$69.46
$69.46K
Michael G Grey
1 Dec 2025
Director
Sold after exercise
50,000
$74.00
$3.70M
Michael G Grey
21 Nov 2025
Director
Sold after exercise
50,000
$70.00
$3.50M
Laura Brege
11 Sep 2025
Director
Sold after exercise
1,491
$75.07
$111.93K
Laura Brege
11 Sep 2025
Director
Sold after exercise
15,509
$74.34
$1.15M
Saira Ramasastry
8 Sep 2025
Director
Sold after exercise
17,000
—
no price
Christopher Peetz
11 Aug 2025
Chief Executive Officer
Sold after exercise
40,000
$62.00
$2.48M
Christopher Peetz
7 Aug 2025
Chief Executive Officer
Sold after exercise
40,000
$55.25
$2.21M
Jolanda Howe
7 Aug 2025
SVP, Global Controller
Sold after exercise
10,000
$58.00
$580.00K
Saira Ramasastry
3 Jun 2025
Director
Sold after exercise
2,500
$45.74
$114.35K
Jolanda Howe
17 Mar 2025
SVP, Global Controller
Sold after exercise
1,806
$44.36
$80.11K
Jolanda Howe
17 Mar 2025
SVP, Global Controller
Sold after exercise
2,789
$44.75
$124.80K
Jolanda Howe
17 Mar 2025
SVP, Global Controller
Sold after exercise
50,111
$44.33
$2.22M
Jolanda Howe
17 Mar 2025
SVP, Global Controller
Sold after exercise
2,900
$44.21
$128.22K
Christopher Peetz
3 Mar 2025
Chief Executive Officer
Sold after exercise
20,608
$47.19
$972.49K
Christopher Peetz
3 Mar 2025
Chief Executive Officer
Sold after exercise
19,392
$46.61
$903.86K
Jolanda Howe
14 Nov 2024
SVP, Global Controller
Sold after exercise
2,500
$47.10
$117.75K
Pamela Vig
24 Jun 2024
Chief Scientific Officer
Sold after exercise
30,559
$34.00
$1.04M
Saira Ramasastry
5 Jun 2024
Director
Sold after exercise
5,000
$25.68
$128.40K
Jolanda Howe
5 Dec 2023
SVP, Global Controller
Sold after exercise
2,500
$32.40
$81.00K
Michael G Grey
14 Sep 2023
Director
Sold after exercise
14,216
$32.00
$454.91K
Michael G Grey
13 Sep 2023
Director
Sold after exercise
392
$32.00
$12.54K
Michael G Grey
8 Jun 2023
Director
Sold after exercise
14,608
$29.00
$423.63K
Michael G Grey
3 May 2023
Director
Sold after exercise
14,608
$28.00
$409.02K

What was left out

Form 4 filings counted 314
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 49
Sales at will 79
Transactions with no price 2
Shares from compensation/vesting 77,812,862
Sales filed before the plan box existed 19
History held since 18 Jul 2019